OIAM
RDY icon

OFI Invest Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

OFI Invest Asset Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,277,200
Closed -$8M – 138
2023
Q1 		$8M Buy
+2,277,200
New +$24.6M 0.04% 92

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OFI Invest Asset Management's RDY Position: Q2 2023 in Review

OFI Invest Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2023, closing a stake of 2,277,200 shares — an estimated $8M sold.

OFI Invest Asset Management first reported a position in RDY in Q1 2023 and held it in 1 quarter. The position peaked at $8M in Q1 2023. 193 funds tracked by Wall St. Rank hold RDY as of Q2 2023.

  • OFI Invest Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2023 after selling out during the quarter.
  • OFI Invest Asset Management sold 2,277,200 Dr. Reddy's Laboratories shares in Q2 2023, an estimated $8M.
  • OFI Invest Asset Management first reported a position in Dr. Reddy's Laboratories in Q1 2023 and held it in 1 quarter.
  • OFI Invest Asset Management's Dr. Reddy's Laboratories position peaked at $8M in Q1 2023.
  • 193 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2023.

Based on OFI Invest Asset Management's 13F filing for Q2 2023, filed 31 Jul 2023.